Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OncoTherapy Science Inc.

www.oncotherapy.co.jp

Latest From OncoTherapy Science Inc.

OncoTherapy Hit By Dropped Alliances

The Japanese bioventure OncoTherapy Science (OTS) has been hit by the discontinuation of alliances with two compatriot firms for some of its key pipeline cancer projects.

BioPharmaceutical Japan

OncoTherapy Surges On TOPK Inhibitor Promise

Shares in OncoTherapy Sciences (OTS) surged in Tokyo on Oct. 24 after the Japanese bioventure published promising early findings with a novel anticancer small molecule, OTS964.

BioPharmaceutical Japan

Lorus Therapeutics: New CEO, new focus for lead candidate

When William Rice was brought in as a consultant to take a look at Lorus Therapeutics and its pipeline of cancer drug candidates, he saw an opportunity to advance the Canadian company's lead small molecule LOR-253 in a faster, targeted way.

Cancer Canada

Shionogi gets choosy as it sets global R&D priorities

Shionogi may be dogged by lingering perceptions that it is a Japan-focused firm heavily reliant on domestic sales of aging anti-infectives with a relatively weak R&D portfolio.

Metabolic Disorders Cardiovascular
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • OncoTherapy Science Inc.
  • Senior Management
  • Kensuke Tomita, Pres. & CEO
  • Contact Info
  • OncoTherapy Science Inc.
    Phone: (81) 44 820 8251
    Kanagawa Sc. Pk. R&D D11F
    3-2-1 Sakado
    Takatsu-ku, Kawasaki City, 213-0012
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register